Cellular and Molecular NeuroTherapies


 

Deglon_2.jpg                                 Tenenbaum_2.jpg

Prof Nicole Déglon                                       Dr Liliane Tenenbaum
Assoc. Professor                                            Privat-Docent, Group Leader
Head of laboratory, Head of CRN                   
 

Laboratory’s activity
The laboratory’s activities are focusing on the development and validation of innovative neurotherapies and neuromodulation strategies. The three principal investigators are focusing on:
> Modulation of neuroinflammation and drug-inducible gene therapy of Parkinson’s disease.
> Underlying molecular and environmenental mechanisms in Huntington’s disease (HD).
> Pre-clinical development of molecular therapies for Huntington’s disease (HTT gene editing).
 

Additional information: UNIL web site

 

 

Bâtiment Champ de l'Air - Rue du Bugnon 21 - CH-1011 Lausanne
Switzerland
Tel. +41 79 556 97 74
Centre Hospitalier Universitaire Vaudois (CHUV)